Eric Sherman

20PUBLICATIONS

86CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Natural language processingMolecular targetsPhycology (incl. marine grasses)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|May 08, 2026

Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trial.

|Jun 18, 2025

Optimizing Outcomes After Transoral Robotic Surgery for Oropharyngeal Carcinoma: Reflections on the ASCO Guideline.

Amir H Safavi, Nadeem Riaz, Eric J Sherman

|Oct 15, 2024

Performance of Retrieval-Augmented Large Language Models to Recommend Head and Neck Cancer Clinical Trials.

Tony K W Hung, Gilad J Kuperman, Eric J Sherman

|Oct 01, 2024

Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma.

Antoine Desilets, Joris L Vos, Nora Katabi

|Jun 26, 2024

Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers.

Jena D French, Bryan R Haugen, Francis P Worden

|May 24, 2024

Reply to A.S. Garden.

Nancy Y Lee, Eric J Sherman, Nadeem Riaz

Pageof 4

Frequent Collaborators

Nancy Y Lee

Luc G T Morris

Nadeem Riaz

Alan L Ho

Ian Ganly

Jung Julie Kang

Shrujal S Baxi

Lori J Wirth

Jonathan E Leeman

Kaveh Zakeri

Frequent Collaborators

Nancy Y Lee

Luc G T Morris

Nadeem Riaz

Alan L Ho